RDNT RadNet Inc.

RadNet Announces the Agenda for its November 11, 2025 Investor Day

RadNet Announces the Agenda for its November 11, 2025 Investor Day

LOS ANGELES, Nov. 04, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services and a premier global developer of digital health solutions, is pleased to unveil the agenda for the company’s Investor Day.

The event will take place on Tuesday, November 11, 2025 from 9:00 a.m. to 2:30 p.m. Eastern Standard Time at the Nasdaq MarketSite in New York City. In-person attendance is by invitation only and investors can request such consideration by emailing . Those unable to participate onsite can view a live webcast at or see an archived replay of the event in the .

Titled “On the Leading Edge of Healthcare: Advancing Imaging Through Innovation and Technology,” the Investor Day will feature presentations from select RadNet senior executives and clinical leaders who will share the company’s current and longer-term strategic priorities, market opportunities and innovation roadmap.

The agenda is as follows:

  • 9:00 to 9:20 a.m. – Opening Remarks and Financial Overview
  • 9:20 to 11:00 a.m. – Expert Clinical Spotlights and Services Division Presentation
  • 11:00 to 11:30 a.m. – Q&A Session
  • 12:15 to 1:15 p.m. – Digital Health Division Presentation
  • 1:15 to 1:45 p.m. – Discussion About Unique Synergy of Services and Digital Health
  • 1:45 to 1:55 p.m. – Value-Creation Plan Towards 2028
  • 2:00 to 2:30 p.m. – Q&A Session

In-person attendees will have the exclusive opportunity to engage with RadNet’s leadership, talk with clinical and research experts and view the following demonstrations of RadNet’s DeepHealth cloud-native AI products:

  • Breast Suite – A portfolio of solutions designed to enhance quality, workflows and other aspects of diagnosing breast cancer.
  • Diagnostic Suite – Imaging platform that unites picture archiving and communications systems (PACS), multi-modality viewing, automated reporting, workflow tools and various AI-empowered clinical processes.
  • TechLive – Vendor-agnostic, remote scanning and radiology management solution designed to extend expert support for MR, ultrasound, CT and PET/CT across large, multi-site operations.
  • Patient Engagement – A portfolio of solutions aimed at improving patient scheduling, onboarding, follow-up interactions and online payments.

About RadNet, Inc.

RadNet, Inc. is a leading provider of outpatient diagnostic imaging services in the United States, with a network of 405 owned and/or operated imaging centers. The company’s markets include Arizona, California, Delaware, Florida, Maryland, New Jersey, New York and Texas. In addition, RadNet provides radiology information technology and artificial intelligence solutions marketed under the DeepHealth brand, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry. Together with contracted radiologists, and inclusive of full-time and per diem employees and technologists, RadNet has over 11,000 team members. For more information, visit .

Contact:

RadNet, Inc.

Mark Stolper

Executive Vice President and Chief Financial Officer

310-445-2928

Or

Jane Mazur

Senior Vice President, Corporate Communications

Investor Relations:

Addo IR



EN
04/11/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on RadNet Inc.

 PRESS RELEASE

DeepHealth Unveils Industry’s Most Comprehensive Portfolio of Native C...

DeepHealth Unveils Industry’s Most Comprehensive Portfolio of Native Clinical AI Solutions at ECR 2026  DeepHealth is introducing in Europe its cloud-first integrated portfolio combining clinical AI, multi-modality viewing and reporting, which is designed to improve outcomes, efficiency and access to care VIENNA, March 04, 2026 (GLOBE NEWSWIRE) -- DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today unveils at ECR 2026 the industry's most comprehensive portfolio of native clinical AI solutions and services acros...

 PRESS RELEASE

RadNet, Inc. Reminds Investors of the Dedicated Conference Call and Pr...

RadNet, Inc. Reminds Investors of the Dedicated Conference Call and Presentation About the Recently Completed Acquisition of Gleamer SAS LOS ANGELES, March 04, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, reminds investors that on Thursday, March 5, 2026, investors are invited to join a dedicated conference call and presentation to hear more details about the recently completed acquisition of Gleamer SAS and RadNet’s Digital H...

 PRESS RELEASE

RadNet, Inc. to Present at the Raymond James 47th Annual Institutional...

RadNet, Inc. to Present at the Raymond James 47th Annual Institutional Investors Conference on Tuesday, March 3rd, 2026 LOS ANGELES, March 02, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer will be presenting at the Raymond James 47th Annual Institutional Investors Conference in Orlando, Florida on, Tuesday, March 3, 2026 at 2:15 p.m. E...

 PRESS RELEASE

RadNet Reports Fourth Quarter 2025 Results, Including Record Revenue a...

RadNet Reports Fourth Quarter 2025 Results, Including Record Revenue and Adjusted EBITDA⁽¹⁾ and Releases 2026 Financial Guidance Total Company Revenue increased 14.8% to a quarterly record of $547.7 million in the fourth quarter of 2025 from $477.1 million in the fourth quarter of 2024; Revenue from the Digital Health reportable segment (inclusive of intersegment revenue) increased 48.2% to $27.9 million in the fourth quarter of 2025 from $18.9 million in the fourth quarter of 2024Total Company Adjusted EBITDA(1) was a quarterly record of $87.7 million in the fourth quarter of 2025 as compa...

 PRESS RELEASE

RadNet Acquires Gleamer, Making RadNet’s DeepHealth the Largest Provid...

RadNet Acquires Gleamer, Making RadNet’s DeepHealth the Largest Provider of Radiology Clinical AI Solutions Worldwide Based in Paris, France, Gleamer serves over 700 customer contracts worldwide with a broad portfolio of FDA-cleared and CE-marked solutions for musculoskeletal, breast, lung and neurologic applications.Gleamer’s leadership in routine imaging, and particularly X-ray, is unparalleled through the breadth and scale of its cloud-first AI solutions. DeepHealth, combined with Gleamer’s solutions will provide the industry’s most comprehensive portfolio of native clinical AI solutio...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch